Clinical Trial Detail

NCT ID NCT03486314
Title A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

Therapies

Carboplatin + Docetaxel + MLN4924 + Paclitaxel

MLN4924 + Rifampin

Age Groups: senior adult

No variant requirements are available.